Region Jaemtland Haerjedalen — Clinical Trial Site

16 Registered trials

11 Currently recruiting

Organisation

Region Jaemtland Haerjedalen

Location

Ostersund, Sweden

Identifier

ORG-100043455

Address

Kyrkgatan 12, 831 50, Sweden

Departments

Infectious diseases
Kirurgklinik
Kliniskt Forskningscentrum
Lungmottagningen Område Medicin
Medicin
Medicin kliniken
Njursektionen Östersunds sjukhus
Oncology
Östersunds sjukhus, Kyrkgatan 12, 831 50 Östersund, Hjärtmottagningen
Östersunds sjukhus, Kyrkgatan 12, 831 50 Östersund, Infektionskliniken
Östersunds sjukhus, Kyrkgatan 12, 831 50 Östersund, Smittskyddsenheten
Östersunds sjukhus, Kyrkgatan 16. KFC plan 6 T Mooe ikm studier
Pediatrics
Region Jämtland Härjedalen
Surgical Department
Women's Clinic, Östersunds Sjukhus, 831 83 Östersund

Clinical trials at this site (16)

Search interface

Randomized Open Label Trial Evaluating Efficacy and Safety of Intravenous Immunoglobulin (IVIg, Privigen) as Add-on to SoC Versus SoC Alone … Pending

2025-522756-97-00 COVID-19 and Severely Impaired B-cell Function 4
A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRES… Recruiting

2025-522170-36-00 Diabetes Mellitus, Type 1 5 2026-02-03
A Trial to Test How AZD0780 Affects Serious Heart, Stroke, or Vascular Problems in Patients with Heart, Stroke or Vascular Disease or at Hig… Recruiting

2025-520519-14-00 Atherosclerotic Cardiovascular Disease 5 2025-09-03
Sclerotherapy of hydro and spermatoceles with 2ml Aetoxysclerol 30mg/ml vs. a combination of 2ml Aetoxysclerol 30mg/ml and 25ml of ethanol 9… Recruiting

2022-502284-38-00 Spermatocele 5 2025-05-05
Concomitant HPV vaccination and HPV screening for rapid elimination of HPV infection and cervical cancer in Sweden Recruiting

2024-518857-41-00 HPV infection and related diseases, such as cervical in 6 2024-11-29
A study to learn more about how well sevabertinib works and how safe it is compared with standard treatment, in participants who have advanc… Recruiting

2024-511319-91-00 Advanced non-small cell lung cancer with HER2 (ERBB2) m 5 2024-10-23
Staphylococcus aureus Network Adaptive Platform trial (SNAP) Recruiting

2023-503582-35-00 Staphylococcus aureus bacteremia 6 2023-10-26
Alternative antibiotics to multidrug-resistant UTIs Recruiting

2024-513294-41-00 Urinary tract infection and/or bacteremia caused by ext 6 2023-04-17
SACK Recruiting

2022-501600-10-00 Atrial fibrillation and Chronic Kidney Disease stage 5 5 2023-02-07
FI-3, Fidelia Recruiting

2024-518243-38-00 Fecal incontinence in female and male patients 5 2022-04-20
OPTION – OutPatienT InductiON: Labour induction in an outpatient setting - a multicentre randomized controlled trial Recruiting

2023-507164-39-00 Induction of labour 6 2021-12-01
Optimized pharmacologic treatment for broken heart (takotsubo) syndrome Recruiting

2022-501874-21-00 Takotsubo syndrome 6 2020-12-15
EVOLVE-MI Ended

2023-509268-26-00 Dyslipidemia 6 2024-01-08
A study to test asundexian for preventing a stroke caused by a clot in participants after an acute ischemic stroke or after a high-risk tran… Ended

2023-503793-20-00 Prevention of ischemic stroke in patients post acute no 5 2023-01-18
Non-inferiority study of GSK3511294 (depemokimab) compared with mepolizumab or benralizumab in participants with severe asthma with an eosin… Ended

2023-510230-84-00 Severe asthma with an eosinophilic phenotype 5 2021-05-28
Evaluation of a Renin Inhibitor, Aliskiren, Compared to Enalapril, in C3 Glomerulopathy Ended

2024-515892-36-00 C3 glomerulopathy 4 2020-01-01